182 related articles for article (PubMed ID: 20718749)
1. Interaction between anandamide and sphingosine-1-phosphate in mediating vasorelaxation in rat coronary artery.
Mair KM; Robinson E; Kane KA; Pyne S; Brett RR; Pyne NJ; Kennedy S
Br J Pharmacol; 2010 Sep; 161(1):176-92. PubMed ID: 20718749
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries.
White R; Ho WS; Bottrill FE; Ford WR; Hiley CR
Br J Pharmacol; 2001 Oct; 134(4):921-9. PubMed ID: 11606334
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta.
Herradón E; Martín MI; López-Miranda V
Br J Pharmacol; 2007 Nov; 152(5):699-708. PubMed ID: 17704831
[TBL] [Abstract][Full Text] [Related]
4. Requirement for sphingosine kinase 1 in mediating phase 1 of the hypotensive response to anandamide in the anaesthetised mouse.
Greig FH; Nather K; Ballantyne MD; Kazi ZH; Alganga H; Ewart MA; Zaborska KE; Fertig B; Pyne NJ; Pyne S; Kennedy S
Eur J Pharmacol; 2019 Jan; 842():1-9. PubMed ID: 30359564
[TBL] [Abstract][Full Text] [Related]
5. Anandamide-induced relaxation of sheep coronary arteries: the role of the vascular endothelium, arachidonic acid metabolites and potassium channels.
Grainger J; Boachie-Ansah G
Br J Pharmacol; 2001 Nov; 134(5):1003-12. PubMed ID: 11682448
[TBL] [Abstract][Full Text] [Related]
6. Role of Ca2+-dependent potassium channels in in vitro anandamide-mediated mesenteric vasorelaxation in rats with biliary cirrhosis.
Yang YY; Lin HC; Huang YT; Lee TY; Hou MC; Wang YW; Lee FY; Lee SD
Liver Int; 2007 Oct; 27(8):1045-55. PubMed ID: 17845532
[TBL] [Abstract][Full Text] [Related]
7. Endothelium-dependent mechanisms of the vasodilatory effect of the endocannabinoid, anandamide, in the rat pulmonary artery.
Baranowska-Kuczko M; MacLean MR; Kozłowska H; Malinowska B
Pharmacol Res; 2012 Sep; 66(3):251-9. PubMed ID: 22627170
[TBL] [Abstract][Full Text] [Related]
8. Anandamide mediates hyperdynamic circulation in cirrhotic rats via CB(1) and VR(1) receptors.
Moezi L; Gaskari SA; Liu H; Baik SK; Dehpour AR; Lee SS
Br J Pharmacol; 2006 Dec; 149(7):898-908. PubMed ID: 17043671
[TBL] [Abstract][Full Text] [Related]
9. A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery.
White R; Hiley CR
Br J Pharmacol; 1997 Dec; 122(8):1573-84. PubMed ID: 9422801
[TBL] [Abstract][Full Text] [Related]
10. Reduced endothelium-dependent relaxation to anandamide in mesenteric arteries from young obese Zucker rats.
Lobato NS; Filgueira FP; Prakash R; Giachini FR; Ergul A; Carvalho MH; Webb RC; Tostes RC; Fortes ZB
PLoS One; 2013; 8(5):e63449. PubMed ID: 23667622
[TBL] [Abstract][Full Text] [Related]
11. Short Periods of Hypoxia Upregulate Sphingosine Kinase 1 and Increase Vasodilation of Arteries to Sphingosine 1-Phosphate (S1P) via S1P
Alganga H; Almabrouk TAM; Katwan OJ; Daly CJ; Pyne S; Pyne NJ; Kennedy S
J Pharmacol Exp Ther; 2019 Oct; 371(1):63-74. PubMed ID: 31371480
[TBL] [Abstract][Full Text] [Related]
12. Evidence of a novel site mediating anandamide-induced negative inotropic and coronary vasodilatator responses in rat isolated hearts.
Ford WR; Honan SA; White R; Hiley CR
Br J Pharmacol; 2002 Mar; 135(5):1191-8. PubMed ID: 11877326
[TBL] [Abstract][Full Text] [Related]
13. Role of pre-junctional CB1, but not CB2 , TRPV1 or GPR55 receptors in anandamide-induced inhibition of the vasodepressor sensory CGRPergic outflow in pithed rats.
Marichal-Cancino BA; Altamirano-Espinoza AH; Manrique-Maldonado G; MaassenVanDenBrink A; Villalón CM
Basic Clin Pharmacol Toxicol; 2014 Mar; 114(3):240-7. PubMed ID: 24118786
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors.
Wagner JA; Járai Z; Bátkai S; Kunos G
Eur J Pharmacol; 2001 Jul; 423(2-3):203-10. PubMed ID: 11448486
[TBL] [Abstract][Full Text] [Related]
15. Mesenteric vasodilation mediated by endothelial anandamide receptors.
Wagner JA; Varga K; Járai Z; Kunos G
Hypertension; 1999 Jan; 33(1 Pt 2):429-34. PubMed ID: 9931142
[TBL] [Abstract][Full Text] [Related]
16. The endocannabinoid anandamide causes endothelium-dependent vasorelaxation in human mesenteric arteries.
Stanley CP; Hind WH; Tufarelli C; O'Sullivan SE
Pharmacol Res; 2016 Nov; 113(Pt A):356-363. PubMed ID: 27633407
[TBL] [Abstract][Full Text] [Related]
17. Anandamide-mediated CB1/CB2 cannabinoid receptor--independent nitric oxide production in rabbit aortic endothelial cells.
McCollum L; Howlett AC; Mukhopadhyay S
J Pharmacol Exp Ther; 2007 Jun; 321(3):930-7. PubMed ID: 17379772
[TBL] [Abstract][Full Text] [Related]
18. Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol.
Ho WS; Randall MD
Br J Pharmacol; 2007 Mar; 150(5):641-51. PubMed ID: 17245358
[TBL] [Abstract][Full Text] [Related]
19. Effects of anandamide on potassium channels in rat ventricular myocytes: a suppression of I(to) and augmentation of K(ATP) channels.
Li Q; Ma HJ; Song SL; Shi M; Ma HJ; Li DP; Zhang Y
Am J Physiol Cell Physiol; 2012 Mar; 302(6):C924-30. PubMed ID: 22173869
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of endothelium-dependent relaxation evoked by anandamide in isolated human pulmonary arteries.
Baranowska-Kuczko M; Kozłowska H; Kozłowski M; Schlicker E; Kloza M; Surażyński A; Grzęda E; Malinowska B
Naunyn Schmiedebergs Arch Pharmacol; 2014 May; 387(5):477-86. PubMed ID: 24682422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
